Intellia Therapeutics
The Head of Clinical Development leads the cross-functional Clinical Development Team, providing strategic and medical leadership for clinical development activities across the company's product portfolio, including HAE and TTR therapies. This role involves defining development strategy, overseeing clinical trials, and ensuring regulatory compliance while collaborating with key stakeholders to advance life-changing medicines. The position requires a physician scientist with hands-on expertise and a collaborative leadership style to drive innovation and patient-focused outcomes.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2014
Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
1 week ago
Intellia Therapeutics: Why The Clinical Hold Lift Isn't A Total Victory (NASDAQ:NTLA)
3 days ago
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Intellia Therapeutics.
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
2 weeks ago
Medical Director, Clinical Development
Scholar Rock
Medical Director/Sr. Director, Clinical Research
Scholar Rock
Senior Clinical Scientist
Bristol Myers Squibb
Director, Oncology Clinical Pharmacology Modeling & Simulation
GSK plc
Senior Director, Clinical Development Scientist, Pulmovant
Pulmovant
Executive Medical Director, Clinical Development - Immunology
lifelancer